Inventor
Martin C. Wright
Inventor
Boston, MA, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides22%
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C12NMicroorganisms or enzymes16%
C40BCombinatorial chemistry12%
C07HSugars9%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
10,406,251PD-L1 binding polypeptides for imaging201910,221,232Methods of treating cancer by administering IGF-IR binding molecules201910,183,987Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules20199,862,758'Inhibitors of type 2 vascular endothelial growth factor receptors'20189,771,411'Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules'20179,328,157'Inhibitors of type 2 vascular endothelial growth factor receptors'20169,017,655'Bispecific EGFR/IGFIR binding molecules'20158,609,613'Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides'20138,470,332'Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR'20138,343,501'Bispecific EGFR/IGFIR binding molecules'20138,324,362'Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors'20127,858,739'Inhibitors of type 2 vascular endothelial growth factor receptors'20107,847,062'Pharmacokinetic modulation and compositions for modified FN3 polypeptides'20106,846,655'Methods for generating highly diverse libraries'20056,623,926'Methods for producing 5-nucleic acid-protein conjugates'20035,650,294'Isolated promoter and terminator of elongation factor 1-.alpha.'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997Based in Biberach an der Riss, DE· patent location history
2003–2005Based in Cambridge, MA, US· patent location history
2010–2019Patents assigned to BRISTOL MYERS SQUIBB CO (13)· patent assignee history
2010–2016Based in Boston, MA, US· patent location history
2012–2013Patents assigned to WRIGHT MARTIN C (4)· patent assignee history
2012–2013Patents assigned to CHEN YAN (2)· patent assignee history
2012–2013Patents assigned to GETMANOVA ELENA (2)· patent assignee history
2013Patents assigned to CAMPHAUSEN RAY (2)· patent assignee history
2015–2019Based in Belmont, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 13 | 2010–2019 |
| WRIGHT MARTIN Cself | 4 | 2012–2013 |
| CAMPHAUSEN RAY | 2 | 2013 |
| CHEN YAN | 2 | 2012–2013 |
| GETMANOVA ELENA | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Boston, Massachusetts, US | 7 | 2010–2016 |
| Belmont, Massachusetts, US | 6 | 2015–2019 |
| Cambridge, Massachusetts, US | 2 | 2003–2005 |
| Biberach an der Riss, DE | 1 | 1997 |